We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-13.83%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.51B
AUM Growth
-$1.01B
Cap. Flow
+$139M
Cap. Flow %
2.14%
Top 10 Hldgs %
20.49%
Holding
891
New
87
Increased
331
Reduced
275
Closed
84

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$60.9M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$30.7M
3
BIIB icon
Biogen
BIIB
+$19.7M
4
MA icon
Mastercard
MA
+$18.7M
5
BMY icon
Bristol-Myers Squibb
BMY
+$18M

Top Sells

Rank Stock Value
1
TSRO
TESARO, Inc.
TSRO
+$32.8M
2
EC icon
Ecopetrol
EC
+$29.1M
3
AET
Aetna Inc
AET
+$20.2M
4
XOM icon
ExxonMobil
XOM
+$19.6M
5
AMGN icon
Amgen
AMGN
+$19.2M

Sector Composition

Rank Sector Weight
1 Healthcare 35.31%
2 Technology 15.37%
3 Financials 11.61%
4 Consumer Discretionary 8.19%
5 Communication Services 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BFH icon
351
Bread Financial
BFH
$4.29B
$3.38M 0.05%
28,225
+23,491
+496% +$3.68M
LXRX icon
352
Lexicon Pharmaceuticals
LXRX
$991M
$3.38M 0.05%
509,000
– –
UGI icon
353
UGI
UGI
$7.91B
$3.35M 0.05%
62,861
-24,205
-28% -$1.35M
ES icon
354
Eversource Energy
ES
$28.1B
$3.33M 0.05%
51,270
+11,439
+29% +$745K
FL
355
DELISTED
Foot Locker
FL
$3.31M 0.05%
62,313
+57,601
+1,222% +$2.89M
ARQL
356
DELISTED
Arqule Inc
ARQL
$3.23M 0.05%
1,164,728
+12,001
+1% +$45.8K
BMO icon
357
Bank of Montreal
BMO
$125B
$3.22M 0.05%
49,365
-145
-0.3% -$10.7K
AKAM icon
358
Akamai
AKAM
$16.4B
$3.22M 0.05%
52,713
+41,181
+357% +$2.74M
BAX icon
359
Baxter International
BAX
$12.1B
$3.22M 0.05%
48,913
+11,507
+31% +$773K
PTLA
360
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$3.21M 0.05%
164,300
– –
IPGP icon
361
IPG Photonics
IPGP
$3.81B
$3.16M 0.05%
27,907
-1,811
-6% -$241K
RVTY icon
362
Revvity
RVTY
$12.1B
$3.14M 0.05%
40,000
– –
KEY icon
363
KeyCorp
KEY
$24.1B
$3.12M 0.05%
211,326
-6,315
-3% -$111K
NBL
364
DELISTED
Noble Energy, Inc.
NBL
$3.1M 0.05%
165,125
+31,826
+24% +$814K
CDK
365
DELISTED
CDK Global, Inc.
CDK
$3.09M 0.05%
64,567
-9,015
-12% -$476K
F icon
366
Ford
F
$58.5B
$3.06M 0.05%
399,622
+2,347
+0.6% +$20.9K
LH icon
367
Labcorp
LH
$24.7B
$3.03M 0.05%
27,877
+890
+3% +$119K
ATO icon
368
Atmos Energy
ATO
$29.7B
$2.99M 0.05%
32,293
+20,028
+163% +$1.91M
TFC icon
369
Truist Financial
TFC
$63.7B
$2.99M 0.05%
69,116
+725
+1% +$34.8K
ULTI
370
DELISTED
Ultimate Software Group Inc
ULTI
$2.99M 0.05%
12,216
-748
-6% -$198K
MYOK
371
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$2.98M 0.05%
61,000
– –
TMUS icon
372
T-Mobile US
TMUS
$190B
$2.98M 0.05%
46,797
-31
-0.1% -$2.08K
DVA icon
373
DaVita
DVA
$15.2B
$2.97M 0.05%
57,689
-10,071
-15% -$645K
PH icon
374
Parker-Hannifin
PH
$124B
$2.95M 0.05%
19,767
-186
-0.9% -$30.1K
EQR icon
375
Equity Residential
EQR
$25.2B
$2.94M 0.05%
44,608
+31,218
+233% +$2.1M
13 14
15
16 17

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2018 Portfolio in Review

As of Q4 2018, Candriam SCA held 891 positions worth $6.51B, down 13% from $7.52B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA's Q4 2018 filing shows 87 new, 331 increased, 275 reduced and 84 closed positions. Its largest new stake was Azul: 501,000 shares worth $13.9M. The largest sale was TESARO, Inc., an estimated $32.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2018 buy was Azul: 501,000 shares worth $13.9M.
  • Candriam SCA added most to Celgene Corp in Q4 2018, an estimated $60.9M increase.
  • Candriam SCA's biggest Q4 2018 reduction was TESARO, Inc., cutting an estimated $32.8M.
  • Candriam SCA fully exited Aetna Inc in Q4 2018, selling an estimated $20.2M.
  • Candriam SCA's ten largest holdings make up 20% of its $6.51B portfolio in Q4 2018.
  • Candriam SCA opened 87 new positions and closed 84 in Q4 2018.
  • Candriam SCA's portfolio value fell 13% quarter-over-quarter to $6.51B.

Based on Candriam SCA's 13F filing for Q4 2018, filed 14 Feb 2019.